Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy
April 07, 2021 08:00 ET
|
Immutep Limited
Sydney, AUSTRALIA, April 07, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for...